Discovery of novel drug targets in schistosomes

Schistosomes are parasites that cause human schistosomiasis, a neglected tropical disease affecting over 260 million people across the globe. New drug targets are needed to help combat the disease. This project will build on current research in the Walker laboratory and will aim to elucidate new drug targets by developing and deploying novel high-content screening approaches and developmentally-advanced schistosome life stages.

This project offers an excellent opportunity to become trained in molecular parasitology. Candidates must demonstrate strong interest in molecular and/or medical parasitology, have appropriate training/educational background in relevant areas and satisfy Kingston University entry requirements. In all cases a master’s degree or equivalent qualification or other evidence of research skills and experience is preferred but not essential.